Adage Capital Partners
VTAE

Adage Capital Partners’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Adage Capital Partners’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,400,000
Closed -$36.7M – 752
2016
Q2 		$36.7M Hold
3,400,000
– – 0.1% 245
2016
Q1 		$22.5M Buy
3,400,000
+1,250,000
+58% +$11.4M 0.06% 342
2015
Q4 		$38.9M Buy
2,150,000
+717,996
+50% +$9.88M 0.1% 237
2015
Q3 		$15.8M Buy
1,432,004
+407,004
+40% +$4.32M 0.04% 434
2015
Q2 		$14.8M Buy
1,025,000
+625,000
+156% +$8.49M 0.04% 479
2015
Q1 		$4.68M Buy
+400,000
New +$5.4M 0.01% 634

Other funds holding VTAE

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners's VTAE Position: Q3 2016 in Review

Adage Capital Partners sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 3,400,000 shares — an estimated $36.7M sold.

Adage Capital Partners first reported a position in VTAE in Q1 2015 and held it in 6 quarters. The position peaked at $38.9M in Q4 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

  • Adage Capital Partners reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Adage Capital Partners sold 3,400,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $36.7M.
  • Adage Capital Partners first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 6 quarters.
  • Adage Capital Partners's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $38.9M in Q4 2015.
  • 98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.